For now, the situation is a delay, not a cancellation. Nothing in the reporting suggests Congress's approved numbers have been overturned.

But scientists have learned to read delays carefully. In recent years, funding freezes and policy reviews have sometimes preceded deeper cuts.

Takeaway: the money is approved but not moving, and that alone creates uncertainty for US research.

Who is affected?

Federal science agencies across the board sit in the path of this decision. Any agency that receives an annual appropriation from Congress needs the White House's green light to put its budget into effect.

Universities and independent laboratories feel it second-hand. Much of their research income originates as federal grants, so a pause at the agency level echoes through campus budgets.

The full scale of the impact isn't yet clear. How long the stall lasts will determine whether it registers as a paperwork lag or a genuine disruption to research schedules.

Is this normal?

Budget mechanics involve some built-in lag every year. Agencies rarely receive funds on day one.

What catches attention here is the word "stalls" — a holdup beyond the routine, serious enough for a major science publication to flag it.

Watchers of federal spending will look for two signals next: whether the White House issues the spending guidance, and whether it attaches conditions to the approved funds. Either move would clarify whether this is simple delay or something more deliberate.

Takeaway: delays happen, but one big enough to make headlines deserves monitoring.

What comes next?

The immediate question is timing. Once the administration releases the budget details, agencies can resume their normal grant cycles and the backlog begins to clear.

If the stall stretches on, pressure will likely build from research institutions, universities, and members of Congress who voted for the spending and expect it delivered.

For now, the situation remains preliminary, and the full picture — which agencies are affected most, how long the hold will last, and what it means for individual grants — is still developing.

Bottom line: Congress approved the money, the White House is holding it up, and US scientists are waiting.